Bruce I. LaMont

407 total citations
8 papers, 319 citations indexed

About

Bruce I. LaMont is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Bruce I. LaMont has authored 8 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Computational Theory and Mathematics and 2 papers in Organic Chemistry. Recurrent topics in Bruce I. LaMont's work include Computational Drug Discovery Methods (3 papers), Renin-Angiotensin System Studies (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Bruce I. LaMont is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Renin-Angiotensin System Studies (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Bruce I. LaMont collaborates with scholars based in United States. Bruce I. LaMont's co-authors include Joshua Boger, Linda S. Payne, E H Ulm, Martin Poe, Edward H. Blaine, Terry W. Schorn, Debra S. Perlow, Daniel F. Veber, Daniel H. Rich and Tsau-Yen Lin and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and Biochemical Society Transactions.

In The Last Decade

Bruce I. LaMont

8 papers receiving 296 citations

Peers

Countries citing papers authored by Bruce I. LaMont

Since Specialization

Citations

This map shows the geographic impact of Bruce I. LaMont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce I. LaMont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce I. LaMont more than expected).

Fields of papers citing papers by Bruce I. LaMont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce I. LaMont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce I. LaMont. The network helps show where Bruce I. LaMont may publish in the future.

Co-authorship network of co-authors of Bruce I. LaMont

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce I. LaMont. A scholar is included among the top collaborators of Bruce I. LaMont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce I. LaMont. Bruce I. LaMont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency 1988 ·Journal of Medicinal Chemistry ·Mark G. Bock, Robert M. DiPardo, B. Evans, Roger Freidinger, Kenneth E. Rittle, Linda S. Payne, Joshua Boger, Willie L. Whitter, Bruce I. LaMont	30
2	Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini 1987 ·Journal of Medicinal Chemistry ·Mark G. Bock, Robert M. DiPardo, B. Evans, Kenneth E. Rittle, Joshua Boger, Martin Poe, Bruce I. LaMont, Robert J. Lynch, E H Ulm	9
3	Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analog inhibitors containing a novel analog of statine 1985 ·Journal of Medicinal Chemistry ·Joshua Boger, Linda S. Payne, Debra S. Perlow, (unknown), Martin Poe, Edward H. Blaine, E H Ulm, Terry W. Schorn, Bruce I. LaMont	111
4	Design of proteolytically-stable, peptidal renin inhibitors and determination of their fate in vivo 1985 ·Regulatory Peptides ·Joshua Boger, Carl D. Bennett, Linda S. Payne, E H Ulm, Edward H. Blaine, Carl F. Homnick, Terry W. Schorn, Bruce I. LaMont, Daniel F. Veber	12
5	A uniquely potent renin inhibitor and its unanticipated plasma binding component 1985 ·Journal of Medicinal Chemistry ·B. Evans, Kenneth E. Rittle, Mark G. Bock, Carl D. Bennett, Robert M. DiPardo, Joshua Boger, Martin Poe, E H Ulm, Bruce I. LaMont	11
6	Renin inhibitors containing 2-substituted statine 1984 ·Biochemical Society Transactions ·Daniel F. Veber, Mark G. Bock, Stephen F. Brady, E H Ulm, David W. Cochran, Graham Smith, Bruce I. LaMont, Robert M. DiPardo, Martin Poe, Roger Freidinger, B. Evans, Joshua Boger	7
7	Novel renin inhibitors containing the amino acid statine 1983 ·Nature ·Joshua Boger, (unknown), E H Ulm, Martin Poe, Edward H. Blaine, George M. Fanelli, Tsau-Yen Lin, Linda S. Payne, Terry W. Schorn, Bruce I. LaMont, (unknown), Inez I. Stabilito, Daniel F. Veber, Daniel H. Rich, (unknown)	137
8	The intracellular metabolism of iodine in carcinogenesis 1979 ·Biological Trace Element Research ·Bernard A. Eskin, Charles E. Sparks, Bruce I. LaMont	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact